Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol sedation in oral surgery under general anesthesia
ChiCTR2300070054Phase 4Not yet recruiting
- Sponsor
- Nanjing Stomatological Hospital
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in Maxillofacial Disorders (2 arms), sponsored by Nanjing Stomatological Hospital. Primary endpoints: Sedation and Analgesia. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Maxillofacial Disorders
Beyond the preview
Go deeper on ChiCTR2300070054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070054.